abrocitinib Tablets 50 mg, 100 mg, 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #27657

This pharmaceutical company is a comprehensive entity focused on the research, development, and production of various medications. Established in 1949, it boasts over 16 successful FDA inspections across its diverse production facilities. With a team of 17 R&D personnel and a staff exceeding 200 employees, they specialize in prescription medications, over-the-counter drugs, and dietary supplements. Their portfolio encompasses several key therapy areas such as cardiovascular health, central nervous system disorders, infectious diseases, and vitamin deficiencies. They offer various dosage forms including tablets, capsules, and oral solutions. Notably, the company holds GMP certifications and possesses multiple product patents, showcasing their commitment to quality and innovation. They operate primarily in the EU and North America.